The novel TRV/TAPSE ratio parameter correlated with disease severity indicators (including the WHO FC class, the 6MWT, NT-proBNP levels, and survival) in adults with PAH or CTEPH. This evidence concerns the gene NPPB and pulmonary arterial hypertension.